Tag: Cyltezo
Boehringer Ingelheim settles litigation over Humira biosimilar
Humira is a medication used to treat Crohn’s disease, psoriasis, ulcerative colitis and several forms of arthritis.
Boehringer Ingelheim gets FDA approval for chronic inflammatory diseases drug
Among the diseases that Cyltezo is meant to treat are moderate to severe active rheumatoid arthritis, psoriatic arthritis, adult Crohn’s disease and ulcerative colitis.